Wealthfront Advisers’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Buy
2,794
+131
+5% +$34.8K ﹤0.01% 683
2026
Q1
$292K Buy
2,663
+1,337
+101% +$190K ﹤0.01% 942
2025
Q4
$221K Buy
+1,326
New +$222K ﹤0.01% 995

Other funds holding ALAB

Wealthfront Advisers's ALAB Position: Q2 2026 in Review

Wealthfront Advisers increased its Astera Labs (ALAB) stake by 4.9% in Q2 2026, buying an estimated $34.8K and bringing the position to 2,794 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #683.

Wealthfront Advisers first reported a position in ALAB in Q4 2025 and has held it in 3 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Wealthfront Advisers held 2,794 shares of Astera Labs worth $1.35M as of Q2 2026.
  • Wealthfront Advisers bought 131 Astera Labs shares in Q2 2026, an estimated $34.8K.
  • Astera Labs made up ﹤0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #683 holding.
  • Wealthfront Advisers first reported a position in Astera Labs in Q4 2025 and has held it in 3 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.